WHAT WILL IT TAKE TO beat childhood cancer?
Research is how we create new solutions that can save lives – in bigger ways than we ever imagined.
BE A PART OF THE CURE AND
double your impact.
Without more funding these stats won’t change. That’s where you can help! Continued research advances treatments for children and saves lives.
WHAT WILL IT TAKE TO beat childhood cancer?
Research is how we create new solutions that can save lives – in bigger ways than we ever imagined.
BE A PART OF THE CURE AND
double your impact.
Without more funding these stats won’t change. That’s where you can help! Continued research advances treatments for children and saves lives.
Real Stories. Real Impact.
Here’s how your dollars continue to advance research for pediatric cancer.
1981
At age 12, in 1981, Lauren was given a diagnosis of severe aplastic anemia (a rare cancer with no known treatment) and a 10% chance of survival. 30 YEARS later, she is a miraculous story of success, still… (READ MORE)
Under the care of Dr. Abdel Ragab, Emory University pediatric oncologist and founder of CURE Childhood Cancer, Lauren was accepted into an experimental trial testing a new antibody drug, anti-thymocyte globulin (ATG). Miraculously, Lauren was among the 10% who would be CURED via ATG therapy.
“I survived….and others would go on after me to defy the odds…. to increase the odds and to give life to a profoundly life-threatening diagnosis. Research is part of my miracle.”
Lauren served on CURE’s Board of Directors for 20+ years and is now on our Advisory Council, using her experience and passion to help other patients and their families navigate the challenges of childhood cancer. In her own powerful words:
“I serve because there were people who came before me who believed children deserve better odds and more out of life. Those people believed in the power of research, and it saved my life. Children with cancer need our help today as much as they did 30 years ago.”
2007
In 2007, at age 11, Nick was diagnosed with aplastic anemia – a cancer his doctors told him was rare, but treatable. After three rounds of treatment, over four years, Nick’s body wasn’t responding, until… (READ MORE)
The same anti-thymocyte globulin (ATG) therapy that miraculously cured Lauren – now with a 67% positive response rate (up from 10% in 1981) – was prescribed as a frontline treatment for Nick. Though effective for so many others, Nick’s cancer was not responsive to ATG.
Nick was referred to the National Institute of Health and joined a new clinical trial for a drug called Eltrombopag, which works by causing the cells in the bone marrow to produce more platelets. Following a six-month trial, Nick received a bone marrow transplant on May 21, 2013, at the age of 17. His sister’s bone marrow was a half-match for him. Doctors combined her marrow with stem cells from a donated umbilical cord.
This research led to Nick’s cure, and ultimately led him here to CURE, where now 28 and healthy, Nick uses his passion to fuel our mission to find cures for all children with cancer.
2024
Research done at the time of Lauren’s treatment led to new, more effective treatment for Nick. Your support of CURE empowers us to continue the research that will make a life-changing difference for children and families… (READ MORE)
- 17,000+ kids in America are diagnosed with cancer each year
- Only 4% of federal cancer research funds are dedicated to childhood cancers
- Most children with cancer today are treated with drugs developed decades ago
Continued research is our best chance to cure childhood cancer.
Empowered by YOUR contributions, research funded by CURE is leading the way. We invest $6+ million annually in specific research projects at top pediatric centers nationwide, to:
- Deliver genetically-informed, “personalized” cancer solutions through precision medicine
- Conduct research that is likely to have a clinical or therapeutic impact within 2-3 years
- Solve recurrent and hard-to-treat cancers with no effective treatments
This research is the lifeblood of our efforts and helps CURE deliver cancer treatments that are:
- LESS TOXIC – harnessing natural immune responses vs. chemotherapies
- MORE EFFECTIVE – new therapies for childhood cancers that lack effective treatments today
- MORE PRECISE – targeting therapies to the specific genetics of each child’s cancer
